1.Repayment and/or pre-payment, in part or full, of certain borrowings availed by our Company and our Material Subsidiaries;
2.Capital expenditure to be incurred by the Company for purchase of new equipment and machinery for the facilities in Hyderabad;
3.Capital expenditure to be incurred by one of our Material Subsidiaries, namely, Aragen Biologics Private Limited for the facility in Bengaluru towards purchase of new equipment and machinery for the following: a.Expansion of biologics drug substance capacity (“Drug Substance Expansion”); and b.Establishment of biologics drug product fill and finish capability (“Fill and Finish Line Establishment”); and
4.General corporate purposes
Plot 28 A Ida Nacharam
Hyderabad
Telangana
500076
040-66929989
compliances@aragen.com
www.aragen.com
KFIN Technologies Ltd.
Magellanic Cloud has informed that Provigil Surveillance, a wholly owned subsidiary of the company, has received a Purchase Order from Nayara Energy, valued at Rs. 44,60,400/-. The Purchase Order is for the implementation of an AI-powered Automatic Number Plate Recognition (ANPR) and Video Analytics Platform across selected Retail Outlets and Oil Depots of Nayara Energy. The aforesaid Purchase Order has been awarded in the ordinary course of business of the Company and is aligned with its core business of providing integrated surveillance, security and technology solutions. The Company remains committed to executing the project with the highest standards of quality, efficiency and operational excellence while continuing to pursue similar opportunities across the energy, transportation, government and critical infrastructure sectors.
The above information is a part of company’s filings submitted to BSE.
In compliance with Regulation 30 read with Para A (7) of Part A of Schedule III of SEBI Listing Regulations, Escorts Kubota has informed that, Manish Sharma has been appointed as ‘President-Agri Business’ (Senior Management Personnel) of the Company with effect from September 21, 2026. The requisite disclosure pursuant to SEBI Master Circular No. HO/49/14/14(7)2025CFDPOD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure I. The date and time of occurrence of the event is September 21, 2026, at 09:00 A.M.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Aragen Life Sciences Ltd. IPO is ₹0.00 - 0.00 crore.
The Aragen Life Sciences Ltd. IPO opens for subscription on and closes on .
The price range of Aragen Life Sciences Ltd. IPO is ₹0.00 to ₹0.00.
The lot size of Aragen Life Sciences Ltd. IPO is shares.
The registrar of Aragen Life Sciences Ltd. IPO is KFIN Technologies Ltd..
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.